The global CAR T-cell therapy market is witnessing substantial growth, driven by increasing occurrence of cancer and positive regulatory guidelines. Key players in the market are investing in research to broaden their product portfolio and meet the growing need for effective cancer treatments. Furthermore, advancements in CAR T-cell therapy method